Gabify Gains Investor Backing to Accelerate Early Screening and Therapy Systems

Sahil Chopra, Founder and Chief Executive Officer of Gabify, and Ankur Mittal, Co-founder of Inflection Point Ventures, said the funding will support clinical validation, technology development, and wider access to early screening and intervention systems.

Gabify, a health technology startup focused on neurodevelopmental care, has raised 175000 dollars in a pre seed funding round led by Inflection Point Ventures, with additional support through a government backed grant.
The company has also received 25 lakh rupees under the Nidhi Seed Support Scheme from GH Raisoni Technology Business Incubator Foundation. The funding will be used for clinical validation, technology enhancement, and team expansion as the company works to scale its platform.

Founded in 2023, Gabify is building an AI based platform for early screening and therapy management of speech and neurodevelopmental disorders, including autism and ADHD. The system combines voice and vision based AI to analyse speech patterns, facial expressions, eye movement, and behavioural indicators across more than 189 clinically validated parameters aligned with global diagnostic frameworks.
The platform also uses a human in loop approach, where clinical experts review AI generated outputs to ensure accuracy and reliability in assessments. The company said its system can reduce assessment time by up to 70 percent, allowing clinicians to serve more patients while maintaining clinical standards.

Ankur Mittal, Co-founder, Inflection Point Ventures, said, “Addressing neurodevelopmental challenges at an early stage plays a critical role in shaping a child’s future, yet it remains one of the most underserved areas in the healthcare ecosystem. Gabify is tackling this gap through a strong blend of clinical validation and AI led innovation, enabling faster and more accurate identification of developmental conditions.”
Gabify has already tested its platform across more than 35 preschool and daycare centres in India during its private beta phase. It is currently being used by schools, hospitals, private practices, and non profit organisations.

Sahil Chopra, Founder and Chief Executive Officer, Gabify, said, “Our goal with Gabify is to ensure that no child is left behind simply due to delayed diagnosis or lack of access. We are building technology that supports clinicians, assists parents, and improves early intervention outcomes.”
The company is part of the fourth cohort of IPV IdeaSchool, a programme focused on early stage startups, and has been recognised among the top 10 startups by DreamDeal, an initiative led by Anupam Mittal.

Gabify said it aims to impact one million children by 2028 through a mix of business and community focused deployment models, including B2B, B2C, and CSR programmes.
The broader market opportunity for neurodevelopmental care is estimated at 110 billion dollars globally, supported by rising diagnosis rates, increased adoption of AI in healthcare, and growing demand for early intervention systems.

At Prittle PrattleNews, featuring you virtuously, we celebrate the commitment and innovation. Led by Editor-in-Chief Smruti Bhalerao, our platform is dedicated to sharing impactful stories that inspire change and create awareness. Follow us on LinkedIn, Instagram, and YouTube for more stories that matter.